Alkaline Ceramidase 3 (ACER3) Antibody
221€ (50 µg)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
Alkaline Ceramidase 3 (ACER3) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx326187
tested applications
ELISA, WB, IHC, IF/ICC
Description
ACER3 Antibody is a Rabbit Polyclonal against ACER3.
Documents del producto
Instrucciones
Data sheet
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | Alkaline Ceramidase 3 (ACER3) |
| Host | Rabbit |
| Reactivity | Human, Mouse |
| Recommended Dilution | ELISA: 1/40000, WB: 1/500 - 1/2000, IHC: 1/100 - 1/300, IF/ICC: 1/200 - 1/1000. Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Polyclonal |
| Conjugation | Unconjugated |
| Isotype | IgG |
| Purification | Purified by affinity chromatography. |
| Size 1 | 50 µg |
| Size 2 | 100 µg |
| Form | Liquid |
| Tested Applications | ELISA, WB, IHC, IF/ICC |
| Buffer | PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. |
| Availability | Shipped within 5-10 working days. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| UniProt ID | Q9NUN7 |
| Gene ID | 55331 |
| Alias | APHC,PHCA,PLDECO |
| Background | Antibody anti-ACER3 |
| Status | RUO |
Descripción
ACER3 is an endoplasmic reticulum-localized ceramidase that specializes in hydrolyzing unsaturated ceramides into sphingosine and free fatty acids, optimizing its activity in alkaline pH environments. It is highly expressed in metabolically active and neuronal tissues, such as the brain, liver, and pancreas, where it regulates sphingolipid metabolism and supports processes such as cell survival, apoptosis, autophagy, and stress responses. ACER3 plays a particularly critical role in the nervous system, where sphingolipid homeostasis is essential for neuronal function and survival. Mutations in the ACER3 gene have been associated with hereditary spastic paraplegia, a rare neurodegenerative condition marked by spasticity and progressive weakness. Additionally, ACER3 is implicated in metabolic diseases and cancer, where its regulation of sphingolipids impacts key signaling pathways. By balancing ceramide and sphingosine levels, ACER3 supports cellular adaptation to stress and maintains bioactive lipid equilibrium, making it a potential therapeutic target for neurodegenerative disorders, metabolic dysfunctions, and tumor progression.
Related Products
Alkaline Ceramidase 3 (ACER3) Antibody
ACER3 hydrolyzes only phytoceramide into phytosphingosine and free fatty acid. Does not have reverse activity.
Ver Producto
Alkaline Ceramidase 3 (ACER3) Antibody
ACER3 Antibody is a Rabbit Polyclonal against ACER3.
Ver Producto